Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Latest News
Browsing: Prostate
The VISION trial showed that Lu-177-PSMA-617 improved survival when added to standard treatment of men with PSMA-positive metastatic castrate-resistant prostate…
The Trio Study suggested performing both MRI-guided and systematic 12-core biopsies was the most surefire way to detect grade group…
In 2018 the USPSTF did an about-face once again on PSA screening, reversing its 2012 recommendation against it. This cross-sectional…
Top Line: Should men receiving salvage prostate fossa radiation also receive ADT and pelvic nodal radiation? The Study: RTOG 9601…
Top Line: Individualized decisions on the best treatment for localized prostate cancer usually boils down to expected toxicity. The Study:…
Enzalutamide combined with androgen deprivation therapy (ADT) is a treatment option for men with metastatic, castration sensitive prostate cancer (mCSPC).…
Top Line: Does ultra-hypofractionated prostate radiation cause more toxicity than moderate hypofractionation? The Study: This British Columbian phase 2 trial…
Top Line: Is 24 months of ADT superior to 4 months in men with intermediate and high risk prostate cancer?…
Top Line: While treating elective pelvic nodes in prostate radiation remains controversial, should their inclusion affect decisions of fractionation? The…